Butalbital, Aspirin, Caffeine and Codeine Phosphate (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Butalbital, Aspirin, Caffeine and Codeine Phosphate drug offered from Actavis Pharma, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Butalbital, Aspirin, Caffeine and Codeine Phosphate
SUBSTANCE NAME: CODEINE PHOSPHATE; BUTALBITAL; CAFFEINE; ASPIRIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2006-10-26
END MARKETING DATE: 0000-00-00


Butalbital, Aspirin, Caffeine and Codeine Phosphate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionButalbital, Aspirin, Caffeine and Codeine Phosphate from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 30; 50; 40; 325(mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2006-10-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-3546_5ffcd5c0-9fd7-467e-a947-5b6617289442
PRODUCT NDC: 0591-3546
APPLICATION NUMBER: NDA019429

Other CODEINE PHOSPHATE; BUTALBITAL; CAFFEINE; ASPIRIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Butalbital, Aspirin, Caffeine and Codeine Phosphate